Maria Luisa Palmese
Partner
Intellectual Property | International Business
maria.palmese@wg-law.com | 212-509-4744 | vCard | LinkedIn
About Maria
Maria Luisa Palmese has over 25 years of experience representing clients in patent litigation, patent prosecution and trademark and design protection matters. She maintains a global practice focused on assisting companies with their U.S. IP matters. Her focus is to efficiently and effectively create and maximize value through IP. Maria Luisa is adept at handling intellectual property matters in a wide range of industries, including chemical, pharmaceutical, biotechnology, food, cosmetics, agricultural, as well as design, fashion and entertainment. A skilled litigator, Maria Luisa has represented clients in some of the busiest patent jurisdictions in the U.S. in jury and bench trials, including the Southern District of New York, New Jersey, Delaware and Northern District of Illinois, the Court of Appeals for the Federal Circuit and other courts. She is adept at litigation complex IP disputes across a range of subject matters, including chemicals and chemical processes, pharmaceuticals (including Hatch-Waxman disputes), and cosmetics, materials and designs. She is also an experienced practitioner before the U.S. Patent and Trademark Office, including inter partes proceedings.
Maria Luisa has been named a New York “Super Lawyer” from 2016 – 2020, and Top Woman Attorney in the New York Metro Area since 2016.
Experience
Practice Areas
Intellectual property litigation
Intellectual property licensing
Patent prosecution
Trademark and design protection
Languages
French
Italian
Spanish
Education
Columbia University — J.D. - 1990
Max Planck Institute affiliated Munich Intellectual Property Law Center — LL.M. IP, - 2004
Massachusetts Institute of Technology — S.B. Chemistry - 1987
Massachusetts Institute of Technology — S.B. Humanities and Science (French Language and Literature) - 1987
Admissions
New York
U.S. District Court for the Southern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. Patent and Trademark Office
Professional Associations
AIPPI
INTA
New York City Bar Association
Sigma Xi
FICPI
Representative Experience
Teva in a patent infringement litigation involving Teva's generic equivalent to Procter & Gamble's osteoporosis drug Actonel® Monthly (risedronate monthly administration). Warner Chilcott Co. et al. v. Teva Pharmaceuticals USA et al. (D. Del. C.A. No. 08-627) (favorable decision on summary judgment affirmed on appeal)
Applied Materials in an interference relating to patents on wafer substrates for making integrated circuits. Rozbicki v. Chiang (Int. No. 105,898) (favorable decision affirmed on appeal)
Teva in patent infringement litigations involving Teva's generic equivalents to Gilead's HIV antiretroviral drug Viread®, Truvada® and Atripla® (tenofovir and emtricitabine). Gilead Sciences v. Teva Pharmaceuticals USA (S.D. N.Y. 08-CV-10838 and 10-CV-1796) (settled)
